Vitamin D and retinoids in parathyroid glands (Review)

International Journal of Molecular Medicine

Volumn 3, Issue 4, 1999, Pages 355-361

  Hellman, Per ^a   Liu, Wei ^a   Westin, Gunnar ^a   Törmä, Hans ^b   Åkerström, Göran ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Calcium; Parathyroid; Parathyroid hormone; Proliferation; Retinoids; Vitamin D

Indexed keywords

CALCITRIOL RECEPTOR; CALCIUM BINDING PROTEIN; PARATHYROID HORMONE; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; RETINOL BINDING PROTEIN; TRANSCRIPTION FACTOR; VITAMIN D;

ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HYPERTHYROIDISM; METABOLISM; PARATHYROID GLAND; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; HUMANS; HYPERTHYROIDISM; PARATHYROID GLANDS; PARATHYROID HORMONE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; RETINOL-BINDING PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VITAMIN A; VITAMIN D;

EID: 0033110823     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.4.355     Document Type: Article

References (79)

1. Hellman P, Åkerström G, Juhlin C, Ridefelt P and Rastad J: Pathophysiology of hypcrparathyroidism. In: Current Controversy in Parathyroid Operation and Reoperation. Åkerström G, Juhlin C and Rastad J (eds). R.G. Landes Company, Austin, TX, pp9-22, 1994.
2. 2+)-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993.
3. Garrett JE, Tamir H, Kifor O, Simin RT, Rogers KV, Mithal A, Gagel RF and Brown EM: Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 136: 5202-5211, 1995.
4. Ruat M, Molliver ME, Snowman AM and Snyder SH: Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA 92: 3161-3165, 1995.
5. Bikle DD, Ratnam A, Mauro T, Harris J and Pillai S: Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest 97: 1085-1093, 1996.
6. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303, 1993.
7. Pollak MR, Wu Chou Y-H, Marx SJ, Steinmann B, Cole DEC, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE and Seidman JG: Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93: 1108-1112, 1994.
8. Juhlin C, Holmdahl R, Johansson H, Rastad J, Åkerström G and Klareskog L: Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci USA 84: 2990-2994, 1987.
9. 2+-sensor of human parathyroid cells. Biochem Biophys Res Commun 143: 570-574, 1987.
10. 2+ in cytotrophoblast cells of human placenta. J Biol Chem 265: 8275-8279, 1990.
11. Lundgren S, Hjälm G, Hellman P, Ek B, Juhlin C, Rastad J, Klareskog L, Åkerström G and Rask L: A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cells belonging to the LDL-receptor superfamily. Exp Cell Res 212: 344-350, 1994.
12. 2+ binding receptor with potential intracellular signalling properties. Eur J Biochem 239: 132-137, 1996.
13. Farquhar MG, Kerjaschki D, Lundstrom M and Orlando RA: Gp330 and RAP: the Heymann nephritis antigenic complex. Ann NY Acad Sci 737: 96-113, 1994.
14. 3. Cell 96: 507-515, 1999.
15. 2+ sensing properties the 550 kDa calcium sensor protein. J Histochem Cytochem 45: 383-392, 1997.
16. Hellman P, Ridefelt P, Juhlin C, Åkerström G, Rastad J and Gylfe E: Parathyroid-like regulation of parathyroid hormone-related protein release and cytoplasmic calcium in cytotropho-blast cells of uman placenta. Arch Biochem Biophys 293: 174-180, 1992.
17. Pian M, Dobbs L and Duzgunes N: Positive correlation between free calcium and surfactant secretion in cultured rat alveolar type II cells. Biochem Biophys Acta 960: 43-53, 1988.
18. Willnow T, Hilpert J, Armstrong S, Rohlmann A, Hammer R, Burns D and Herz J: Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 93: 8460-8464, 1996.
19. Wallfelt C, Gylfe E, Larsson R, Ljunghall S, Rastad J and Åkerström G: Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism. J Endocrinol 116: 457-464, 1988.
20. Carling T, Rastad J, Ridefelt P, Gobi A, Hellman P, Öberg K, Rask L, Larsson C, Juhlin C, Åkerström G and Skogseid B: Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression. Surgery 118: 924-931, 1995.
21. Juhlin C, Klareskog L, Nygren P, Ljunghall S, Gylfe E, Rastad J and Åkerström G: Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 122: 2999-3001, 1988.
22. Farnebo F, Enberg U, Grimelius L, Bäckdahl M, Schalling M, Larsson C and Farnebo L-O: Tumor specific decreased expression of calcium sensing receptor message ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 82: 3481-3486, 1997.
23. Kremer R, Bolivar 1, Goltzman D and Hendy GN: Influence of calcium and 1,25-dihydroxycholecaIciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125: 935-941, 1989.
24. Naveh-Many T, Rahamimov R, Livni N and Silver J: Parathyroid cell proliferation in normal and chronic renal failure rats. The effect of calcium, phosphate and vitamin D. J Clin Invest 96: 1786-1793, 1995.
25. Arnold A: Molecular basis of primary hyperparathyroidism. In: The Parathyroids. Levine MA and Bilezikian JP (eds). Raven Press, Ltd, New York, NY, pp407-421, 1994.
26. Farnebo F, The BT, Dotzenrath C, Wassif WS, Svensson A, White I, Betz R, Goretzki P, Sandelin K, Farnebo LO and Larsson C: Differential loss of heterozygosity in familial, sporadic and uremic hyperparathyroidism. Hum Genet 99: 342-349, 1997.
27. Farnebo F, Teh BT, Kytölä S, Svensson A, Phelan C, Sandelin K, Thompson NW, Höög A, Weber G, Farnebo L-O and Larsson C: Alterations of the MEN 1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83: 2627-2630, 1998.
28. Grossman RF and Jossart GH: Hypercalcemic crisis. In: Textbook of Endocrine Surgery. Clark OH and Duh Q-Y (eds). W.B. Saunders Company, Philadelphia, PA, pp432-438, 1997.
29. Lundgrcn E, Ljunghall S, Åkerström G, Hetta J, Mallmin H and Rastad J: Case-control study on symptoms and signs of 'asymptomatic' primary hyperparathyroidism. Surgery 124: 980-986, 1998.
30. Åkerström G, Rudberg C, Grimelius L, Bergström R, Johansson H, Ljunghall S and Rastad J: Histologie parathyroid abnormalities in an autopsy series. Hum Pathol 17: 520-527, 1986.
31. Hedbäck G, Tisell L-E, Bengtsson B-Å, Hedman I and Oden A: Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14: 829-835, 1990.
32. Reichel H and Norman AW: Systemic effects of vitamin D. Annu Rev Med 40: 71-78, 1989.
33. Kobayashi T, Hashimoto K and Yoshikawa K: Growth inhibition of human keratinocytes by 1,25-dihydroxyvitamin D3 is linked to dephosphorylation of retinoblastoma gene product. Biochem Biophys Res Commun 196: 487-493, 1993.
34. Saunders DE, Christensen C, Wappler NL, Schultz JF, Lawrence WD, Malviya VK, Malone JM and Deppe G: Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. Anticancer Drugs 4: 201-208, 1993.
35. Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretiing C, Mörk Hansen C, Colston KV and Carlberg C: Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to a promoter selectivity. J Cell Biochem 66: 552-562, 1997.
36. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ and Wortsman J: Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91: 2552-2555, 1993.
37. Carlberg C: The vitamin D3 receptor in the context of the nuclear receptor superfamily. Endocrine 4: 91-105, 1996.
38. Sorensen H, Binderup L, Calvery MJ, Hoffmeyer L and Rastrup Anderson N: In vitro metabolism of calipotriol (MC903), a vitamin D analogue. Biochem Pharmacol 39: 391-393, 1990.
39. Cheskis B, Lemon BD, Uskokovic M, Lomedico PT and Freedman LP: Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differently affected by analogs of 1,25-dihydroxyvitamin D3. Mol Endocrinol 9: 1814-1824, 1995.
40. Nayeri S, Danielsson C, Kahlen J-P, Schräder M, Mathiasen IS, Binderup L and Carlberg C: The antiproliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-I pathway, but may be related to promoter selectivity. Oncogene 11: 1853-1858, 1995.
41. Morrison NA, Cheng Qi J, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN and Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 367: 284-287, 1994.
42. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Åkerström G and Melhus H: Vitamin D genotypes in hyperparathyroidism. Nat Med 1: 1309-1311, 1995.
43. Carling T, Kindmark A, Hellman P, Holmberg L, Åkerström G and Rastad J: Vitamin D receptor alleles b, a and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1. Biochem Biophys Res Commun 231: 329-332, 1997.
44. 3. Proc Natl Acad Sci USA 89: 8097-8101, 1992.
45. Silver J, Russell J and Sherwood LM: Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 82: 4270-4273, 1985.
46. Cantley LK, Russel J, Lettieri D and Sherwood LM: 1,25-dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117: 2114-2119, 1985.
47. Liu W, Hellman P, Li Q, Yu W-R, Juhlin C, Nordlinder H, Rollman O, Åkerström G, Törmä H and Melhus H: Biosynthesis and function of all-trans- and 9-cis-retinoic acid in parathyroid cells. Biochem Biophys Res Commun 229: 922-929, 1996.
48. Carlberg C and Polly P: Gene regulation by vitamin D3 (In Process Citation). Grit Rev Eukaryot Gene Expr 8: 19-42, 1998.
49. 3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tiss Int 43: 213-218, 1988.
50. Hellman P, Liu W, Törmä H and Åkerström G: Parathyroid cells are targets for retinoids. Bone 23: S452, 1998.
51. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW and Slatopolsky E: Parathyroid hormone suppression by intravenous 1,25-dihydroxy vitamin D. A role for increased sensitivity to calcium. J Clin Invest 83: 1349-1355, 1989.
52. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81: 1598-1606, 1996.
53. Gudas LJ, Sporn MB and Roberts AB: Cellular biology and biochemistry of the retinoids. In: The Retinoids: Biology, Chemistry, and Medicine. Sporn MB, Roberts AB and Goodman DS (eds). Raven Press Ltd., New York, NY, pp443-520, 1994.
54. 3H]retinol is transferred from hepatocytes to stellate cells in liver for storage. Exp Cell Res 150: 186-193, 1984.
55. Kanai M, Raz A and Goodman DS: Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 47: 2025-2044, 1968.
56. De Luca LM: Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5: 2924-2933, 1991.
57. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A and Evans RM: Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6: 329-344, 1992.
58. Zhang XK, Hoffmann B, Tran PB, Graupner G and Pfahl M: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441-446, 1992.
59. Mangelsdorf DJ and Evans RM: The RXR heterodimers and orphan receptors. Cell 83: 841-850, 1995.
60. Giguere V: Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 15: 61-79, 1994.
61. Langenfeld J, Kiyokawa H, Sekula D, Boyle J and Dmitrovsky E: Posttranslational regulation of cyclin Dl by retinoic acid: a chemoprevention mechanism. Proc Natl Acad Sci USA 94: 12070-12074, 1997.
62. Teixeira C and Christine Pratt MA: CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol II: 1191-1202, 1997.
63. Mangiarotti R, Danova M, Alberici R and Pellicciari C: All-trans retinoic acid (ATRA)-induced apoptosis is preceded by Gl arrest in human MCF-7 breast cancer cells. Br J Cancer 77: 186-191, 1998.
64. Chai X, Boerman MH, Zhai Y and Napoli JL: Cloning of a cDNA for liver microsomal retinol dehydrogenase. A tissue-specific, short-chain alcohol dehydrogenase. J Biol Chem 270: 3900-3904, 1995.
65. Romert A, Tuvendal P, Simon A, Dencker L and Eriksson U: The identification of a 9-cis retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis retinoic acid. Proc Natl Acad Sci USA 95: 4404-4409, 1998.
66. Wang X, Penzes P and Napoli JL: Cloning of a cDNA encoding an aldehyde dehydrogenase and its expression in Escherichia coll recognition of retinals as substrate. J Biol Chem 271: 16288-16293, 1996.
67. Urbach J and Rando RR: Isomerization of all-trans retinoic acid to 9-cis retinoic acid. Biochem J 299: 459-465, 1994.
68. Nagao A and Oison JA: Enzymatic formation of 9-cis, 13-cis, and all-trans retinals from isomers of β-carotene. FASEB J 8: 968-973, 1994.
69. Rottman JN, Widom RL, Nadal-Ginard B, Mahdavi V and Karathanasis SK: A retinoic-acid responsive element in the apo-lipoprotein Al gene distinguishes between two different retinoic acid response pathways. Mol Cell Biol 11: 3814-3820, 1991.
70. Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES and Evans RM: A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66: 555-561, 1991.
71. MacDonald PN, Ritter C, Brown AJ and Slatopolsky E: Retinoic acid suppresses parathyroid hormone (PTH) secretion and preproPTH mRNA levels in bovine parathyroid cell culture. J Clin Invest 93: 725-730, 1994.
72. Nemeth E, Steffey ME, Hammerland LG, Hung BC, van Wagenen BC, DelMar EG and Balandrin MFrCalcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95: 4040-4045, 1998.
73. Salusky IB, Kuizon BD, Belin TR, Ramirez JA, Gales B, Segre GV and Goodman WG: Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54: 907-914, 1998.
74. Abe J, Nakano T, Nishii Y, Matsumoto T, Ogata E and Ikeda K: A novel vitamin D3 analogue 22-oxa-1,25-dihydroxyvitamin D3 inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129: 832-837, 1991.
75. Nishii Y, Abe J, Mori T, Brown AJ, Dusso AS, Finch J, Lopez-Hilker S, Morrissey J and Slatopolsky E: The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. Contrib Nephrol 91: 123-128, 1991.
76. Kragballe K: Vitamin D analogues in the treatment of psoriasis. J Cell Biochem 49: 46-52, 1992.
77. Slatopolsky E, Finch J, Ritter C, Denda M, Morrissey J, Brown A and DeLuca H: A new analogue of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in theabsence of hypercalcemia. Am J Kidney Dis 26: 852-860, 1995.
78. Llach F, Keshav G, Goldblat MV, Lindberg JS, Sadler R, Delmez J, Arruda J, Lau A and Slatopolsky E: Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. Am J Kidney Dis 32 (Suppl. 2): S48-S54, 1998.
79. Denda M, Finch J, Brown AJ, Nishii Y, Kubodera N and Slatopolsky E: 1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 50: 34-39, 1996.